SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > $6 Barrons

<< Previous

Bullboard Posts

Next >>

Comment by 25Stone7859on Nov 25, 2022 9:08am

108 Views

Post# 35127763

RE:RE:RE:$6 Barrons

SQIReader: The Barron SQI site is out of date and displays shoddy data. For example, the site states "SQI will report Q4 2015 earnings on 03/02/2023". There are holes everywhere. Why not ask Barrons directly for the research and an explanation?
As for the $2.4 Billion M/C, you tell us what SQI would look like........

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?